| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.42 | 0.008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |